Rachel K. King - 29 Mar 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Apr 2024, 16:05:29 UTC
Prior SEC filing
06 Feb 2023
Next SEC filing
22 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian F. Leaf, Attorney-in-Fact

Key filing fact

Rachel K. King filed Form 4 for GLYCOMIMETICS INC (GLYC) on 02 Apr 2024.

Key facts

  • This page summarizes Rachel K. King's Form 4 filing for GLYCOMIMETICS INC (GLYC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Apr 2024, 16:05.

Change

  • Previous filing in this sequence was filed on 06 Feb 2023.
  • Current net transaction value: +$10,002.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLYC transaction

Common Stock

Award

Transaction value
$10,002
Shares
+3,334
Change %
+0.65%
Price
$3.00
Shares after
515,194
Date
29 Mar 2024
Ownership
Direct
Footnotes
F1
GLYC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,500
Date
29 Mar 2023
Ownership
By RBK LLC
Footnotes
F2
GLYC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
90,660
Date
29 Mar 2023
Ownership
By trusts
Footnotes
F3
GLYC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
45,741
Date
29 Mar 2023
Ownership
By spouse
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares will be issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $10,000.

Footnote F2

The reporting person is co-manager of this entity. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.

Footnote F3

These shares are held by family trusts, for which Ms. King serves as trustee, as follows: 1,741 shares are held by The Langley C. King 1990 Trust, 8,796 shares are held by the 1995 Connor A. King Trust, 8,796 shares are held by the 1995 Langley C. King Trust, 23,301 shares are held by The Connor King 2013 GRAT, 23,301 shares are held by The Langley C. King 2013 GRAT and 24,725 shares are held by The Rachel K. King 2016 GRAT. The total amount excludes 1,741 shares that were previously held by the Connor A. King 1988 Trust, as the trust has terminated and the shares are not beneficially owned by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .